{"id":"NCT00127218","sponsor":"Johns Hopkins University","briefTitle":"High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly","officialTitle":"HDL Increased Plaque Stabilization in the Elderly","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-09","primaryCompletion":"2008-12","completion":"2008-12","firstPosted":"2005-08-05","resultsPosted":"2015-11-09","lastUpdate":"2017-11-06"},"enrollment":145,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Atherosclerosis","Cardiovascular Disease"],"interventions":[{"type":"DRUG","name":"any statin","otherNames":["fluvastatin (Lescol)","pravastatin (Pravachol)","simvastatin (Vytorin)","atorvastatin (Lipitor)","rosuvastatin (Crestor)"]},{"type":"DRUG","name":"niacin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to investigate the added benefits of increased high-density lipoprotein (HDL) cholesterol serum levels over and above those achieved by lipid lowering therapy guided by current guidelines, in older individuals with cardiovascular disease.","primaryOutcome":{"measure":"Changes in Plaque Architecture and Composition Directly Measured by Magnetic Resonance Imaging (MRI) in the Aorta and Carotid Arteries","timeFrame":"18 months","effectByArm":[{"arm":"Niacin Plus Statin","deltaMin":7,"sd":0.2},{"arm":"Placebo Plus Statin","deltaMin":5,"sd":0.2}],"pValues":[]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["9761083","9989957","11757504"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":72},"commonTop":["Coronary Revascularization"]}}